← Back to headlines
Dyne Therapeutics Stock Jumps on Price Target Upgrade
Dyne Therapeutics (DYN) saw its stock rise by 11.8% following a significant triple-digit price target upgrade from analysts.
Sources
Showing 0 of 1 sources
No articles available in your preferred languages.
1 article available in other languages below.
